Silence Therapeutics shares are trading lower after the company reported worse-than-expected Q1 sales results.
Silence Therapeutics PLC Sponsored ADR
Silence Therapeutics PLC Sponsored ADR SLN | 0.00 |
Silence Therapeutics shares are trading lower after the company reported worse-than-expected Q1 sales results.
